2025-12-15
We raised $130M in Series B funding at a $1.3B valuation to build the computer aided design suite for molecules. The round was led by @GeneralCatalyst & @OakHCFT along with existing investors @ThriveCapital, @OpenAI, @_DimensionCap, @Neo, @lachygroom, @MenloVentures, @svangel, [video]
Bloomberg
AI drug discovery startup Chai Discovery raised a $130M Series B led by Oak HC/FT and General Catalyst at a $1.3B valuation, taking its total funding to $225M
Chai Discovery, an artificial intelligence drug-discovery company backed by OpenAI, has raised $130 million to build a “computer-aided design suite” for molecules.